FBLG – fibrobiologics, inc. (US:NASDAQ)
Stock Stats
News
FibroBiologics CEO Issues Letter to Shareholders
FibroBiologics (NASDAQ:FBLG) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference
FibroBiologics Announces Positive Preclinical Results for a Fibroblast Spheroid-derived Chondrocyte (FSdC) Spheroid Therapy for Degenerative Disc Disease [Yahoo! Finance]
FibroBiologics Announces Positive Preclinical Results for a Fibroblast Spheroid-derived Chondrocyte (FSdC) Spheroid Therapy for Degenerative Disc Disease
Form 8-K FibroBiologics, Inc. For: Dec 30
Form EFFECT FibroBiologics, Inc.
Form 424B3 FibroBiologics, Inc.
Form DEFA14A FibroBiologics, Inc.
Form DEF 14A FibroBiologics, Inc. For: Feb 20
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.